DK1532981T3 - Stabile öjendråber, der indeholder latanoprost som den aktive bestanddel - Google Patents

Stabile öjendråber, der indeholder latanoprost som den aktive bestanddel

Info

Publication number
DK1532981T3
DK1532981T3 DK03795230T DK03795230T DK1532981T3 DK 1532981 T3 DK1532981 T3 DK 1532981T3 DK 03795230 T DK03795230 T DK 03795230T DK 03795230 T DK03795230 T DK 03795230T DK 1532981 T3 DK1532981 T3 DK 1532981T3
Authority
DK
Denmark
Prior art keywords
active ingredient
eye drops
latanoprost
drops containing
containing latanoprost
Prior art date
Application number
DK03795230T
Other languages
English (en)
Inventor
Hiroyuki Asada
Akio Kimura
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK1532981T3 publication Critical patent/DK1532981T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
DK03795230T 2002-08-23 2003-08-22 Stabile öjendråber, der indeholder latanoprost som den aktive bestanddel DK1532981T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002243955 2002-08-23
JP2002336242 2002-11-20
PCT/JP2003/010607 WO2004024164A1 (ja) 2002-08-23 2003-08-22 ラタノプロストを有効成分とする安定な点眼液

Publications (1)

Publication Number Publication Date
DK1532981T3 true DK1532981T3 (da) 2008-01-28

Family

ID=31996094

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03795230T DK1532981T3 (da) 2002-08-23 2003-08-22 Stabile öjendråber, der indeholder latanoprost som den aktive bestanddel

Country Status (12)

Country Link
US (2) US20050228048A1 (da)
EP (1) EP1532981B1 (da)
KR (2) KR20100132557A (da)
CN (2) CN100361661C (da)
AT (1) ATE374031T1 (da)
AU (1) AU2003262268A1 (da)
CA (1) CA2496540C (da)
DE (1) DE60316574T2 (da)
DK (1) DK1532981T3 (da)
ES (1) ES2294361T3 (da)
PT (1) PT1532981E (da)
WO (1) WO2004024164A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050057251A (ko) * 2002-09-09 2005-06-16 산텐 세이야꾸 가부시키가이샤 라타노프로스트를 유효 성분으로 하는 투명한 점안액
US7074827B2 (en) 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
ATE412400T1 (de) 2004-11-09 2008-11-15 Novagali Pharma Sa Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential
ES2460967T3 (es) 2005-08-02 2014-05-16 Santen Pharmaceutical Co., Ltd. Método para la prevención de la degradación de una sustancia térmicamente inestable
EP1795183B1 (en) * 2005-12-09 2009-07-15 Teva Pharmaceutical Industries, Inc. Aqueous dispersions and solutions of difficult to dissolve compounds and methods of their preparation
EP1985298A1 (en) 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins
US8673937B2 (en) * 2008-04-23 2014-03-18 Otsuka Pharmaceutical Co., Ltd. Eye-drop preparation and use thereof
WO2010053487A1 (en) * 2008-11-07 2010-05-14 Cydex Pharmaceuticals, Inc. Composition containing sulfoalkyl ether cyclodextrin and latanoprost
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
US20110136872A1 (en) * 2009-12-09 2011-06-09 Burk Robert M Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof
US10272040B2 (en) 2010-08-12 2019-04-30 Nanyang Technological University Liposomal formulation for ocular drug delivery
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
CN110721260A (zh) * 2019-10-29 2020-01-24 深圳市瑞霖医药有限公司 一种新型拉坦前列素滴眼液

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556848A (en) * 1993-12-27 1996-09-17 Senju Pharmaceutical Co., Ltd. Ophthalmic suspension containing diflupredonate
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
WO1997023225A1 (en) * 1995-12-22 1997-07-03 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
JP3480549B2 (ja) * 1996-12-26 2003-12-22 参天製薬株式会社 ジフルオロプロスタグランジン誘導体およびその用途
KR100508227B1 (ko) * 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액
US6646001B2 (en) * 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
WO2000003736A1 (en) * 1998-07-14 2000-01-27 Alcon Laboratories, Inc. Prostaglandin product
JP2001081048A (ja) * 1999-09-10 2001-03-27 Wakamoto Pharmaceut Co Ltd 眼圧降下剤
JP4757970B2 (ja) * 1999-10-14 2011-08-24 久光製薬株式会社 点眼剤組成物
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
JP3876355B2 (ja) * 2000-09-13 2007-01-31 参天製薬株式会社 点眼液
PT1321144E (pt) * 2000-09-13 2011-03-10 Santen Pharmaceutical Co Ltd Colírio
KR20050057251A (ko) * 2002-09-09 2005-06-16 산텐 세이야꾸 가부시키가이샤 라타노프로스트를 유효 성분으로 하는 투명한 점안액

Also Published As

Publication number Publication date
EP1532981A4 (en) 2005-10-12
CA2496540A1 (en) 2004-03-25
ATE374031T1 (de) 2007-10-15
CA2496540C (en) 2011-01-25
DE60316574D1 (de) 2007-11-08
WO2004024164A1 (ja) 2004-03-25
KR101027454B1 (ko) 2011-04-06
ES2294361T3 (es) 2008-04-01
KR20100132557A (ko) 2010-12-17
CN100361661C (zh) 2008-01-16
DE60316574T2 (de) 2008-07-03
EP1532981B1 (en) 2007-09-26
KR20050038624A (ko) 2005-04-27
EP1532981A1 (en) 2005-05-25
CN1684688A (zh) 2005-10-19
CN100591333C (zh) 2010-02-24
CN101023927A (zh) 2007-08-29
US20050228048A1 (en) 2005-10-13
PT1532981E (pt) 2007-12-12
US20110118348A1 (en) 2011-05-19
AU2003262268A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
DK1532981T3 (da) Stabile öjendråber, der indeholder latanoprost som den aktive bestanddel
CA2447924A1 (en) Olopatadine formulations for topical administration
ATE314824T1 (de) Herzfrequenzüberwachungsgerät
EP0642789A4 (da)
CY1108593T1 (el) Συμπυκνωμενο υδατικο διαλυμα αμβροξολης
DE60104872D1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
EP1930024A3 (en) G-CSF solution formulations having long-term stability
NO20050612L (no) Pyrrolidinderivater som oksytocinantagonister
ATE354622T1 (de) Flüssigkristallines medium
HUP0303255A2 (hu) Peszticid hatású 4"-helyettesített avermektin-sók, a vegyületeket tartalmazó készítmények és alkalmazásuk
CR9831A (es) Formulaciones de plaguicidas con riesgo de cristalizacion y procedimiento para su obtencion
DE69913116D1 (de) Orale flüssige lösung enthaltend das antidepressivum mirtazapine
NO20025081L (no) Stabilt flytende preparat
HRP20080544T3 (en) Benzothiazole formulations and use thereof
DK1692092T3 (da) Anvendelse af bis-aminer til forstærkning af den antimikrobielle aktivitet af vandige sammensætninger
EA200501789A1 (ru) Стабильный водный раствор эритропоэтина человека, не содержащий сывороточного альбумина
DE60226836D1 (de) Stabile Elektrolytlösungen enthaltend Taurolidin
RS24504A (en) Selective heribicides based on substituted thien-3-yl- sulfonylamino (thio)carbonyltriazolin (thi)ones and safeners
DK534087A (da) Desinfektionsmiddel indeholdende en stabiliseret hydrogenperoxidoploesning til desinfektion af bloede kontaktlinser
ES2076838T3 (es) Nuevo derivado de la isoindolinona, su preparacion y las composiciones farmaceuticas que le contienen.
ATE333796T1 (de) Flüssige antimikrobielle zusammensetzungen
WO2004005220A3 (fr) Procede de resolution asymetrique d'un racemique faisant intervenir 2,3:4,6-di-o-isopropyilidene-2-keto-l-gulonique
RU2006123317A (ru) Состав раствора эритропоэтина
ATE500730T1 (de) Herbizidzusammensetzungen und ihre verwendung
CR6305A (es) Formulacion concentrada en suspension que contiene pirimetanilo